Carregant...

CRLX101 (formerly IT-101)–A Novel Nanopharmaceutical of Camptothecin in Clinical Development

CRLX101 (formerly IT-101) is a first-in-class nanopharmaceutical, currently in Phase 2a development, which has been developed by covalently conjugating camptothecin (CPT) to a linear, cyclodextrin-polyethylene glycol (CD-PEG) co-polymer that self-assembles into nanoparticles. As a nanometer-scale dr...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Young, Cissy, Schluep, Thomas, Hwang, Jungyeon, Eliasof, Scott
Format: Artigo
Idioma:Inglês
Publicat: Bentham Science Publishers Ltd 2011
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3182091/
https://ncbi.nlm.nih.gov/pubmed/22081768
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2174/157340711795163866
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!